| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Causey Christopher is a Director at United Therapeutics Corporation. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | UTHR United Therapeutics Corporation | Director | Sale+OE | 20 | $490.17 | $9,803.37 | -0.5% | +11.1% | - | |
| Jan 6, 2026 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,000 | $510.00 | $510,000.00 | -19.3% | +11.3% | - | |
| Jan 2, 2026 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,000 | $500.01 | $500,014.60 | -19.3% | +14.8% | - | |
| Sep 24, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,000 | $440.00 | $440,000.00 | -17.1% | +16.3% | - | |
| Sep 2, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 3,000 | $423.21 | $1,269,630.00 | -14.6% | +18.6% | - | |
| Nov 1, 2024 | UTHR United Therapeutics Corp | Director | Sell | 510 | $376.63 | $192,080.33 | -12.2% | -5.8% | +19.1% | |
| Aug 21, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,210 | $349.00 | $422,290.00 | -22.4% | +2.6% | -11.6% | |
| Jun 18, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 3,000 | $304.18 | $912,538.50 | -41.8% | +12.7% | -4.7% | |
| Jun 13, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,000 | $281.53 | $563,054.80 | -32.3% | +20.4% | -1.5% | |
| May 15, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,000 | $272.90 | $545,800.00 | -32.3% | +18.7% | +11.5% |